Modality Solutions’ New Greenwood Lab Slashes Lead Times and Expands Testing
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details
Amicus Therapeutics announces EC approval for Pombiliti™
Amicus Therapeutics announces EC approval for Pombiliti™
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset Pompe Disease. We applaud Amicus and are proud to have contributed to their cold chain over the last seven years with full validation master planning and transport simulation.
Stay on top of the industry trends
You may also like
Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details
Melinta Therapeutics announces FDA approval of REZZAYO™
Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read Details